within Pharmacolibrary.Drugs.ATC.A;

model A12AA20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 0.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00028333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Calcium (different salts in combination) refers to preparations that contain more than one form of calcium salt, commonly administered to supplement dietary calcium intake or to treat and prevent calcium deficiency states such as osteoporosis, hypocalcemia, and rickets. It is widely used and approved for both prescription and non-prescription purposes in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration in healthy adults; as combination formulations, absorption rates and kinetics may vary depending on formulation and salt forms included.</p><h4>References</h4><ol><li><p>Bermejo, M, et al., &amp; Mudie, D (2019). Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses. <i>Pharmaceutics</i> 11(3) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics11030122&quot;>10.3390/pharmaceutics11030122</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30884755/&quot;>https://pubmed.ncbi.nlm.nih.gov/30884755</a></p></li><li><p>Brazier, M, et al., &amp; Richard, MO (1990). [Comparison of the fluoride bioavailability from two oral preparations of monofluorophosphate disodium in combination with various calcium salts]. <i>Therapie</i> 45(3) 235–241. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2363111/&quot;>https://pubmed.ncbi.nlm.nih.gov/2363111</a></p></li><li><p>Setnikar, I, et al., &amp; Barkworth, MF (1998). Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement. <i>Arzneimittel-Forschung</i> 48(12) 1172–1178. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9893933/&quot;>https://pubmed.ncbi.nlm.nih.gov/9893933</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A12AA20;
